Camels’ Role in MERS Contagion Questioned

A study suggests that transmission of the Middle East respiratory syndrome coronavirus from camels to humans is poor.

Written byJenny Rood
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, SANDRA COHEN-ROSE AND COLIN ROSEWhen infected with the Middle East respiratory syndrome coronavirus (MERS-CoV), camels come down with a week-long illness and spew high quantities of pathogen into the air. The commonly-infected mammals have thus been blamed as vectors of the deadly MERS outbreak that has affected nearly 950 people—killing at least 350—since it began in 2012. But according to a study to be published in a coming issue of Emerging Infectious Diseases, MERS-infected camels may not be spreading the coronavirus to humans. Researchers from King Faisal University in Saudi Arabia and the University of Hong Kong tested 11 members of a domestic herd of 70 camels and found that nine were infected with the MERS virus. They then tested the blood of 191 people, 146 with no exposure to the camels and 45 with low to high exposure—including four herdsmen who had daily contact with the animals and who often drank raw camel milk. The researchers found that none of them had antibodies to MERS, which would be present if any of them had been previously infected.

“Our findings do not imply that dromedaries are not a source of infection for humans,” the authors wrote in their paper, but are consistent with observations that “human disease is not directly proportional to potential exposure to a virus that seems to be common in dromedary camels.”

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies